Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
A Double Blind, Placebo Controlled, Randomized, Two Period 4-Arm Trial to Investigate the Dose-Related Efficacy and Safety of Org 26576 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety and effectiveness of Extended-release Guanfacine Hydrochloride for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanEvaluation of Pharmacokinetics and Profile of Clinical Response of Subacute Lisdexamfetamine Dimesylate (Vyvanse) Treatment vs. Clinical Response to Subacute Immediate Release Mixed Amphetamine Salt Therapy in Adult ADHD
This study has finished and is no longer accepting participants.
In New York
Effectiveness of a Tailored Occupational Therapy Intervention for Women With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In New YorkResearchers compared Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in young people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanThe Effectiveness of Videoconferencing on Teaching Parent Training Skills to Parents of Children With ADHD
This study has finished and is no longer accepting participants.
In SacramentoNeurophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Dyslexia: Functional Magnetic Resonance Imaging (fMRI) Measures of Brain Activation During Attention and Reading Tasks Pre- and Post-Atomoxetine Treatment
This study has finished and is no longer accepting participants.
In New HavenThis study evaluated the safety and effectiveness of Extended-release Guanfacine Hydrochloride for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoA Phase III, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled, Forced-dose Titration, Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Adolescents Aged 13-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared SHP465 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanA 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate HCl Extended Release in the Treatment of Adult Patients With Childhood-onset ADHD
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.